Floatz logo

OLMESARTAN MEDOXOMIL

Prehypertension

Virginia Polytechnic Institute and State UniversitySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Prehypertension cohort.

Asset / SponsorPhaseRating
Clonidine
Gary L. Pierce
Phase 2CCC
Hydrochlorothiazide
Gary L. Pierce
Phase 2CCC

Same molecule, other indications

OLMESARTAN MEDOXOMIL is also rated in:

hypertensive disorderDormant
BBB
Indicative ·
75 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BBB
Indicative ·
72 / 100
View asset →
obesity disorderDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →